Evolving approaches in research and care for ovarian cancers: A report from the national academies of sciences, engineering, and medicine

JAMA - Journal of the American Medical Association

Volumn 315, Issue 18, 2016, Pages 1943-1944

  Levine, Douglas A ^a   Karlan, Beth Y ^b   Strauss, Jerome F ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; CA 125 ANTIGEN; TUMOR MARKER;

ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER RESEARCH; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CYTOREDUCTIVE SURGERY; EARLY DIAGNOSIS; ENDOMETRIOSIS; GYNECOLOGIC SURGERY; HUMAN; MOLECULAR PATHOLOGY; OVARY CANCER; OVARY CYST; OVERALL SURVIVAL; PATIENT CARE; PRIORITY JOURNAL; RISK FACTOR; STANDARDIZATION; SURVIVAL RATE; SURVIVAL TIME; BLOOD; CLASSIFICATION; FEMALE; GENETIC SCREENING; MEDICAL RESEARCH; MULTIMODALITY CANCER THERAPY; ORGANIZATION; OVARIAN NEOPLASMS; PATHOLOGY; PROCEDURES; RESEARCH; STANDARDS; TRENDS; UNITED STATES;

BIOMARKERS, TUMOR; BIOMEDICAL RESEARCH; CA-125 ANTIGEN; COMBINED MODALITY THERAPY; FEMALE; GENETIC TESTING; HUMANS; NATIONAL ACADEMY OF SCIENCES (U.S.); OVARIAN NEOPLASMS; RESEARCH REPORT; UNITED STATES;

EID: 84968807541     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.2640     Document Type: Article

References (7)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7-30.
2. National Academies of Sciences, Engineering, and Medicine. Ovarian Cancers: Evolving Paradigms in Research and Care. Washington, DC: National Academies Press; 2016.
3. Bookman MA, Gilks CB, Kohn EC, et al. Better therapeutic trials in ovarian cancer. J Natl Cancer Inst. 2014;106(4):dju029.
4. Perets R, Drapkin R. It's totally tubular⋯ riding the newwave of ovarian cancer research. Cancer Res. 2016;76(1):10-17.
5. Jacobs IJ, Menon U, Ryan A, et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial [published online December 17, 2015]. Lancet. doi:10.1016/S0140-6736(15)01224-6.
6. Bristow RE, Chang J, Ziogas A, Anton-Culver H, Vieira VM. Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status. Gynecol Oncol. 2014;134(1):60-67.
7. Bowtell DD, Böhm S, Ahmed AA, et al. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer. 2015;15(11):668-679.